The Fleming Fund brings evidence and people together to encourage action against drug resistance for a healthier world.

We support low- and middle-income countries to generate, share and use data to improve antimicrobial use and encourage investment in AMR.

News

The Fleming Fund Phase I: A Summary

Date: 26/04/2022

The Fleming Fund's Phase I Report is now available.

Inauguration of upgraded national laboratories, supported by the Fleming Fund, UK Health Security Agency and DAI.

The Fleming Fund has awarded an AMR surveillance project, ‘SEQAFRICA’, with an additional £2.4 million. SEQAFRICA uses the innov…


How does the Fleming Fund’s approach to One Health reflect good practice? How can One Health be evaluated? These are questions bei…

Our independent evaluator, [Itad](https://www.itad.com/project/fleming-fund-independent-evaluation-supplier/), is evaluating whether the…

Programme Update

Case Study: Breaking down AMR barriers in Uganda

Date: 05/08/2022

The Fleming Fund is working with Uganda’s health care system to break down the barriers to disease surveillance by strengthening laborato…


21

Active Country Grants

155

Countries have supplied data on use of antimicrobial medicines in animals to OIE database

65

National Action Plans developed with Fleming Fund support

11

Active Regional Grants

Pending Grants

Fellowship › Bhutan

Bhutan: Policy Fellowship

Status: Fellows Selected

Fellowship › Uganda

Uganda: Professional Fellowship 2

Status: Workplan Development